Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

US spot Bitcoin ETFs recorded $4.06B in net outflows in June 2026, the worst month since launch, as Bitcoin fell to a year-to ...

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Cloudflare AI bot controls now divide crawlers into Search, Agent, and Training categories, letting publishers independently ...

The post Motorola Razr Plus 2026 Review: The Flip Foldable that Finally Brings Balance appeared first on Android Headlines.

Cumulus Neuroscience Announces Publication in Frontiers in Digital Health Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with ...

Acoramidis initiation was associated with rapid kidney-protective activity as exhibited in a hemodynamically mediated, reversible eGFR dip and a placebo-corrected 15.5% reduction in UACR by Day 28 (P ...

For much of the digital age, technological progress has been measured by what people could see. Companies proudly showcased ...

TwelveLabs, a video intelligence company, has raised $100 million in Series B funding. The round was co-led by NEA and NAVER Ventures with participation from Am ...

Public financial management (PFM) and debt management systems are central to the development trajectory of any state. In the case of Liberia, these systems carry an even greater weight because the ...

Researchers at Monash University have built a single nanoscale chip that generates, steers, and electrically reads light-based signals at room temperature, combining three functions that previously ...

In the modern world, digitalization is no longer merely a technological matter. It is a question about the future of the ...